GoAI
Get started
H.U. Group Holdings, Inc. logo

H.U. Group Holdings, Inc.

4544.T

JPXHealthcareMedical - Diagnostics & Research

Open in GoAI

Latest quote

¥3,660

−¥20.00 · -0.54%

Aug 24, 3:30 PM JST

4544.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Industry
Medical - Diagnostics & Research
Sector
Healthcare
Headquarters
JP

Market position

Day range

Current ¥3,660

52-week range

Current ¥3,660

Open
¥3,641
Previous close
¥3,680
Volume
251.1K
Market cap
203.08B JPY
50-day average
¥3,387.62
+8.04% above average
200-day average
¥3,320.59
+10.22% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
205.41B JPY
P/E (TTM)
21.21×
P/B (TTM)
1.5×
P/S (TTM)
0.82×
EV / EBITDA
6.62×
Earnings yield
3.81%
Free cash flow yield
10.72%
Dividend yield
3.42%

Profitability & efficiency

Gross margin
28.91%
Operating margin
2.42%
Net margin
3.86%
Return on equity
4.97%
Return on assets
2.55%
Return on invested capital
1.68%

Financial health

Debt / equity
0.45×
Current ratio
1.72×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends45%28%10%-8%Gross margin, FY2022: 40.96%Gross margin, FY2023: 34.47%Gross margin, FY2024: 26.69%Gross margin, FY2025: 27.65%Gross margin, FY2026: 28.61%Operating margin, FY2022: 18.50%Operating margin, FY2023: 8.96%Operating margin, FY2024: -1.71%Operating margin, FY2025: 1.09%Operating margin, FY2026: 1.93%Net margin, FY2022: 10.84%Net margin, FY2023: 6.01%Net margin, FY2024: -3.19%Net margin, FY2025: 1.14%Net margin, FY2026: 2.76%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 40.96%. Gross margin FY2023 34.47%. Gross margin FY2024 26.69%. Gross margin FY2025 27.65%. Gross margin FY2026 28.61%. Operating margin FY2022 18.50%. Operating margin FY2023 8.96%. Operating margin FY2024 -1.71%. Operating margin FY2025 1.09%. Operating margin FY2026 1.93%. Net margin FY2022 10.84%. Net margin FY2023 6.01%. Net margin FY2024 -3.19%. Net margin FY2025 1.14%. Net margin FY2026 2.76%.

Income trends

Revenue

247.36B JPY+1.78%

Operating income

4.78B JPY+81.06%

Net income

6.82B JPY+147.12%
Income trends across reported periods300.99B JPY188.79B JPY76.6B JPY−35.6B JPYRevenue, FY2022: 272.94B JPYRevenue, FY2023: 260.91B JPYRevenue, FY2024: 236.95B JPYRevenue, FY2025: 243.03B JPYRevenue, FY2026: 247.36B JPYOperating income, FY2022: 50.49B JPYOperating income, FY2023: 23.38B JPYOperating income, FY2024: −4.04B JPYOperating income, FY2025: 2.64B JPYOperating income, FY2026: 4.78B JPYNet income, FY2022: 29.6B JPYNet income, FY2023: 15.68B JPYNet income, FY2024: −7.55B JPYNet income, FY2025: 2.76B JPYNet income, FY2026: 6.82B JPYFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 272.94B JPY. Revenue FY2023 260.91B JPY. Revenue FY2024 236.95B JPY. Revenue FY2025 243.03B JPY. Revenue FY2026 247.36B JPY. Operating income FY2022 50.49B JPY. Operating income FY2023 23.38B JPY. Operating income FY2024 −4.04B JPY. Operating income FY2025 2.64B JPY. Operating income FY2026 4.78B JPY. Net income FY2022 29.6B JPY. Net income FY2023 15.68B JPY. Net income FY2024 −7.55B JPY. Net income FY2025 2.76B JPY. Net income FY2026 6.82B JPY.
Metric (JPY)FY2026FY2025FY2024FY2023FY2022
Revenue247.36B JPY243.03B JPY236.95B JPY260.91B JPY272.94B JPY
Cost of goods sold176.6B JPY175.83B JPY173.72B JPY170.98B JPY161.15B JPY
Gross profit70.77B JPY67.2B JPY63.24B JPY89.92B JPY111.8B JPY
Research and development—10.89B JPY11.26B JPY9.56B JPY7.28B JPY
Selling, general, and administrative65.99B JPY48.08B JPY50.05B JPY51.57B JPY51.18B JPY
Operating expenses65.99B JPY64.56B JPY67.28B JPY66.54B JPY61.31B JPY
Interest income402M JPY508M JPY454M JPY242M JPY45M JPY
Interest expense686M JPY591M JPY399M JPY369M JPY395M JPY
Depreciation and amortization21.76B JPY20.75B JPY20.87B JPY19.69B JPY14.63B JPY
Operating income4.78B JPY2.64B JPY−4.04B JPY23.38B JPY50.49B JPY
Net income6.82B JPY2.76B JPY−7.55B JPY15.68B JPY29.6B JPY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
55%
6 beats, 5 misses, 0 met estimates
Average EPS surprise
-102.68%
11 comparable reports
Latest EPS result
28.46
Estimate 16.11 · Beat by 76.66%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates287.76177.1966.61-43.96Q1 '25BeatQ2 '25BeatQ3 '25MissQ4 '25BeatQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 7, 2025: actual 63.65, estimate 22.34, surprise +184.91%, Beat. Q2 2025, reported May 15, 2025: actual -0.58, estimate -8.71, surprise +93.34%, Beat. Q3 2025, reported Aug 8, 2025: actual -21.08, estimate 3.24, surprise -750.62%, Miss. Q4 2025, reported Nov 11, 2025: actual 24.69, estimate 16.19, surprise +52.50%, Beat. Q1 2026, reported Feb 9, 2026: actual 95.82, estimate 264.88, surprise -63.83%, Miss. Q2 2026, reported May 14, 2026: actual 22.09, estimate 21.28, surprise +3.81%, Beat. Q3 2026, reported Aug 12, 2026: actual 28.46, estimate 16.11, surprise +76.66%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 25.58, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates67.56B64.27B60.98B57.69BQ1 '25MetQ2 '25MissQ3 '25BeatQ4 '25BeatQ1 '26MissQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 7, 2025: actual 62.06B JPY, estimate 62.06B JPY, surprise 0.00%, Met estimate. Q2 2025, reported May 15, 2025: actual 60.98B JPY, estimate 61.15B JPY, surprise -0.29%, Miss. Q3 2025, reported Aug 8, 2025: actual 61.4B JPY, estimate 60.29B JPY, surprise +1.84%, Beat. Q4 2025, reported Nov 11, 2025: actual 63B JPY, estimate 61.75B JPY, surprise +2.02%, Beat. Q1 2026, reported Feb 9, 2026: actual 62.34B JPY, estimate 64.51B JPY, surprise -3.37%, Miss. Q2 2026, reported May 14, 2026: actual 60.63B JPY, estimate 62.67B JPY, surprise -3.25%, Miss. Q3 2026, reported Aug 12, 2026: actual 62.59B JPY, estimate 63.17B JPY, surprise -0.92%, Miss. Q4 2026, reported Nov 5, 2026: actual —, estimate 64.96B JPY, surprise —, Comparison unavailable.

4544.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,973

-0.54%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,815

+0.88%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,975

+0.32%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,205

+0.08%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,862

+1.01%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406

+0.80%

ETFs holding 4544.T

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core TOPIX ETF logoiShares Core TOPIX ETF1475.T
Market value
603.15M
Weight
0.02%
AUM
2.89T JPY
Expense ratio
0.05%
Price / 1D
¥417.7-0.07%
Vanguard Total International Stock ETF logoVanguard Total International Stock ETFVXUS
Market value
17.5M
Weight
0.00%
AUM
646.2B USD
Expense ratio
0.05%
Price / 1D
$87.71+0.78%
Vanguard FTSE Developed Markets ETF logoVanguard FTSE Developed Markets ETFVEA
Market value
11.67M
Weight
0.00%
AUM
315B USD
Expense ratio
0.03%
Price / 1D
$73.42+0.80%
iShares Core MSCI EAFE ETF logoiShares Core MSCI EAFE ETFIEFA
Market value
8M
Weight
0.00%
AUM
195.14B USD
Expense ratio
0.07%
Price / 1D
$100.85+0.86%
Vanguard FTSE All-World ex-US Small-Cap ETF logoVanguard FTSE All-World ex-US Small-Cap ETFVSS
Market value
4.69M
Weight
0.03%
AUM
13.6B USD
Expense ratio
0.06%
Price / 1D
$160.06+0.43%
iShares MSCI EAFE Small-Cap ETF logoiShares MSCI EAFE Small-Cap ETFSCZ
Market value
4.38M
Weight
0.03%
AUM
13.28B USD
Expense ratio
0.40%
Price / 1D
$86.60+0.70%
iShares Core MSCI Total International Stock ETF logoiShares Core MSCI Total International Stock ETFIXUS
Market value
3.06M
Weight
0.01%
AUM
60.91B USD
Expense ratio
0.07%
Price / 1D
$97.945+0.76%
Schwab International Small-Cap Equity ETF logoSchwab International Small-Cap Equity ETFSCHC
Market value
2.77M
Weight
0.05%
AUM
5.73B USD
Expense ratio
0.06%
Price / 1D
$51.25+0.61%

Continue in GoAI

Research 4544.T

research.disclaimer